|
Invited Participants
Jeff Abrams, M.D.
National Cancer Institute
Jeanne M. Adler, R.N.
National Cancer Institute
Michael Atkins, M.D.
Beth Israel Deaconess Medical Center
Menashe Bar-Eli, Ph.D.
University of Texas M.D. Anderson Cancer Center
Boris Bastian, M.D.
University of California, San Francisco
Michael Bittner, Ph.D.
Translational Genomics Research Institute (TGen)
Antonio C. Buzaid,
M.D.
Hospital Sirio-Libanes, Brazil
Luis H. Camacho, M.D.,
M.P.H.
University of Texas M.D. Anderson Cancer Center
Paul B. Chapman, M.D.
Memorial Sloan-Kettering Cancer Center
Lynda Chin, M.D.
Dana-Farber Cancer Institute
Michaele C. Christian,
M.D.
National Cancer Institute
A. Dimitrios Colevas,
M.D.
National Cancer Institute
Thomas Davis, M.D.
National Cancer Institute
Janet Dancey, M.D.
National Cancer Institute
Lyn M. Duncan, M.D.
Harvard Medical School
Alexander Eggermont,
M.D., Ph.D.
Erasmus University Medical Center, Rotterdam
David E. Elder, M.D.
University of Pennsylvania Health System
Julie Ellerhorst,
M.D., Ph.D.
University of Texas M.D. Anderson Cancer Center
Richard Essner, M.D.
John Wayne Cancer Institute
Soldano Ferrone, M.D.,
Ph.D.
Roswell Park Cancer Institute
David E. Fisher, M.D.,
Ph.D.
Dana-Farber Cancer Institute
Keith Flaherty, M.D.
University of Pennsylvania
Lawrence Flaherty,
M.D.
Karmanos Cancer Institute
Douglas L. Fraker,
M.D.
University of Pennsylvania Medical Center
Scott M. Freeman,
M.D.
Onyx Pharmaceuticals, Inc.
Thomas Gajewski, M.D.,
Ph.D.
University of Chicago
Jeffrey E. Gershenwald,
M.D.
University of Texas M.D. Anderson Cancer Center
James S. Goydos, M.D.
Robert Wood Johnson Medical School
Elizabeth A. Grimm,
Ph.D.
University of Texas M.D. Anderson Cancer Center
Louise Grochow, M.D.,
F.A.C.P.
National Cancer Institute
Allan C. Halpern,
M.D.
Memorial Sloan-Kettering Cancer Center
Nicholas Hayward,
Ph.D.
Royal Brisbane Hospital
Meenhard Herlyn, D.V.M.
The Wistar Institute
Peter Hersey, M.D.,
Ph.D.
University of Newcastle
F. Stephen Hodi, M.D.
Dana-Farber Cancer Institute
Patrick Hwu, M.D.
National Cancer Institute
Richard S. Kaplan,
M.D.
National Cancer Institute
Ulrich Keilholz, M.D.
Free University Berlin
Kevin B. Kim, M.D.
University of Texas M.D. Anderson Cancer Center
John M. Kirkwood,
M.D.
University of Pittsburgh Cancer Institute
Philip D. Leming,
M.D.
Cincinnati Hematology Oncology, Inc.
Michael T. Lotze,
M.D.
Molewar Medicine Institute
Tracy G. Lugo, Ph.D.
National Cancer Institute
Richard Marais, M.D.
The Institute of Cancer Research, London
Kim Margolin, M.D.
City of Hope Medical Center
Francesco M. Marincola,
M.D.
National Institutes of Health
William (Bill) Marsch
Melanoma Research Foundation
Martin McMahon, Ph.D.
UCSF Cancer Research Institute
Kelly M. McMasters,
M.D., Ph.D.
University of Louisville
Beverly Meadows, R.N.,
M.S., O.C.N.
National Cancer Institute
Estela E. Medrano,
Ph.D.
Baylor College of Medicine
Paul Meltzer, M.D.,
Ph.D.
National Human Genomics Research Institute
Frank Meyskens, Jr.,
M.D.
University of California, Irvine
Donald L. Morton,
M.D.
John Wayne Cancer Institute
Martin C. Mihm, Jr.,
M.D.
Harvard Medical School
James J. Mulé,
Ph.D.
University of Michigan Health System
Anthony J. Murgo,
M.D.
National Cancer Institute
Geoffrey M. Nichol,
M.D.
Medarex, Inc.
Michael I Nishimura,
Ph.D.
University of Chicago
Steven J. O'Day, M.D.
John Wayne Cancer Institute
Augusto C. Ochoa,
M.D.
Louisiana State University Health Sciences Center
William Pavan, Ph.D.
National Human Genome Research Institute
Linda Pilkington
Melanoma Reserach Foundation
James M. Pluda, M.D.
MedImmune, Inc.
Pamela Pollock, Ph.D.
National Human Genome Research Institute
Victor G. Prieto,
M.D., Ph.D.
University of Texas M.D. Anderson Cancer Center
Sridhar Ramaswamy,
M.D.
Dana-Farber Cancer Institute
Ulf R. Rapp, Ph.D.
Institut fur Medizinische Strahlenkinde und Sellforschung
Douglas S. Reintgen,
M.D.
Lakeland Regional Cancer Center
Nicholas P. Restifo, M.D.
National Cancer Institute
Antoni Ribas, M.D.
University of California, Los Angeles
Ze'ev Ronai, Ph.D.
Mount Sinai School of Medicine
Steven Rosenberg,
M.D., Ph.D.
National Cancer Institute
Tess Schmalbach, M.D.,
Ph.D.
Coley Pharmaceutical Group
Lynn Schuchter, M.D.
University of Pennsylvania Medical Center
Craig, L. Slingluff,
Jr., M.D.
University of Virginia
Michael Smylie, M.B.,
Ch.B.
Cross Cancer Institute
Arthur J. Sober, M.D.
Harvard Medical School
Jeffrey A. Sosman,
M.D.
Vanderbilt University Medical Center
Rachel Taylor, Ph.D.
Immuno-Designed Molecule, Inc.
Magdelaena Thurin,
Ph.D.
National Cancer Institute
Jeffrey M. Trent,
Ph.D.
Translational Genomics Research Institute (TGen)
Margaret Tucker, M.D.
National Cancer Institute
Ralph J. Tuthill,
M.D.
Cleveland Clinic Foundation
Walter J. Urba, M.D.,
Ph.D.
Providence Portland Medical Center
Andrew von Eschenbach,
M.D.
Director, National Cancer Institute
Raymond P. Warrell,
Jr., M.D.
Genta Incorporated
Jeffrey S. Weber,
M.D., Ph.D.
University of Southern California
John K. Whisnant,
M.D.
Coley Pharmaceutical Group
Jedd Wolchok, M.D.,
Ph.D.
Memorial Sloan-Kettering Cancer Center
Roy Wu, M.D., Ph.D.
National Cancer Institute
Michael Yellin, M.D.
Medarex, Inc.
James A. Zwiebel,
M.D., F.A.C.P.
National Cancer Institute
top
of page
|
